1,443 research outputs found
The Ethics of Conducting Clinical Trials With Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure
No full text
Another reason to embrace quadruple medical therapy for heart failure: medications enabling tolerance of each other
No full textEjection fraction in heart failure: just become Emperor's new clothes?
No full textThis article refers to 'A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction - insights from the ESC-HFA EORP Heart Failure Long-Term Registry' by A. Kaplon-Cieslicka et al., published in this issue on pages 335-350
Moving away from symptoms-based heart failure treatment: misperceptions and real risks for patients with heart failure
No full textHeart failure with preserved ejection fraction: underdiagnosed and undertreated in patients with tricuspid regurgitation
No full textImproving Outcome in Patients With Tricuspid Regurgitation: Look At the Kidneys and the Liver!
No full text
Little at a time: trying to understand the battery of benefits of sodium–glucose contransporter 2 inhibitors in heart failure
No full text- …
